Good cop, bad cop: the different faces of NF-κB

Complexes formed from the nuclear factor κB (NF-κB) family of transcription factors are ubiquitously expressed and are induced by a diverse array of stimuli. This results in their becoming activated in a wide variety of different settings. While the functions of NF-κB in many of these contexts have been the subject of intense research and are now well established, it is also clear that there is great diversity in the effects and consequences of NF-κB activation. NF-κB subunits do not necessarily regulate the same genes, in an identical manner, in all of the different circumstances in which they are induced. This review will discuss the different functions of NF-κB, the pathways that modulate NF-κB subunit activity and, in contrast to its more commonly thought of role as a promoter of cancer cell growth and survival, the ability of NF-κB, under some circumstances, to behave as a tumor suppressor.

[1]  E. Kieff,et al.  IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Mueller-Dieckmann,et al.  Tyrosine Phosphorylation of IkB-a Activates NF-kB without Proteolytic Degradation of IkB-a , 1996 .

[3]  M. Mayo,et al.  Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase , 2004, The EMBO journal.

[4]  P. Barker,et al.  Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. , 2005, Cancer research.

[5]  L. Ährlund‐Richter,et al.  Advances in Brief Squamous Cell Carcinomas and Increased Apoptosis in Skin with Inhibited Rel / Nuclear Factor-k B Signaling 1 , 1999 .

[6]  Gioacchino Natoli,et al.  Interactions of NF-κB with chromatin: the art of being at the right place at the right time , 2005, Nature Immunology.

[7]  A. Hoffmann,et al.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.

[8]  David Baltimore,et al.  Genetic analysis of NF‐κB/Rel transcription factors defines functional specificities , 2003, The EMBO journal.

[9]  M. Merville,et al.  Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation , 2005 .

[10]  M. Mayo,et al.  SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival. , 2004, Molecular cell.

[11]  D. Haller,et al.  IKKβ and Phosphatidylinositol 3-Kinase/Akt Participate in Non-pathogenic Gram-negative Enteric Bacteria-induced RelA Phosphorylation and NF-κB Activation in Both Primary and Intestinal Epithelial Cell Lines* , 2002, The Journal of Biological Chemistry.

[12]  B. Aggarwal,et al.  Nuclear factor-kappaB: its role in health and disease. , 2004, Journal of molecular medicine.

[13]  L. Stark,et al.  Nucleolar Sequestration of RelA (p65) Regulates NF-κB-Driven Transcription and Apoptosis , 2005, Molecular and Cellular Biology.

[14]  W. Greene,et al.  Shaping the nuclear action of NF-kappaB. , 2004, Nature reviews. Molecular cell biology.

[15]  N. Perkins,et al.  Regulation of NF‐κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor , 2005, The EMBO journal.

[16]  H. Ljunggren,et al.  Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  W. Greene,et al.  p53 Induces NF-κB Activation by an IκB Kinase-independent Mechanism Involving Phosphorylation of p65 by Ribosomal S6 Kinase 1* , 2004, Journal of Biological Chemistry.

[18]  M. Hung,et al.  β-catenin interacts with and inhibits NF-κB in human colon and breast cancer , 2002 .

[19]  K. Vousden,et al.  Loss of Nuclear Factor-κB Is Tumor Promoting but Does Not Substitute for Loss of p53 , 2004, Cancer Research.

[20]  Michael Karin,et al.  IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy. , 2005, The Journal of clinical investigation.

[21]  S. Miyamoto,et al.  Sequential Modification of NEMO/IKKγ by SUMO-1 and Ubiquitin Mediates NF-κB Activation by Genotoxic Stress , 2003, Cell.

[22]  E. Schmidt,et al.  IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development , 2001, Cell.

[23]  N. Perkins,et al.  p53 Represses Cyclin D1 Transcription through Down Regulation of Bcl-3 and Inducing Increased Association of the p52 NF-κB Subunit with Histone Deacetylase 1 , 2003, Molecular and Cellular Biology.

[24]  Stuart Thomson,et al.  MSK2 and MSK1 mediate the mitogen‐ and stress‐induced phosphorylation of histone H3 and HMG‐14 , 2003, The EMBO journal.

[25]  P. Khavari,et al.  Divergent gene regulation and growth effects by NF-κB in epithelial and mesenchymal cells of human skin , 2003, Oncogene.

[26]  N. Perkins,et al.  p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor Suppressor , 2003 .

[27]  David F. Kashatus,et al.  NF-κB and IκBα Are Found in the Mitochondria , 2003, The Journal of Biological Chemistry.

[28]  M. Schmitz,et al.  Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import. , 2004, Journal of immunology.

[29]  David F. Kashatus,et al.  The Nuclear Factor κB Subunits RelA/p65 and c-Rel Potentiate but Are Not Required for Ras-Induced Cellular Transformation , 2004, Cancer Research.

[30]  D. Longo,et al.  Phosphorylation of RelA/p65 on Serine 536 Defines an IκBα-independent NF-κB Pathway* , 2005, Journal of Biological Chemistry.

[31]  A. Livolsi,et al.  Tumor Necrosis Factor-α Activation of Nuclear Transcription Factor-κB in Marrow Macrophages Is Mediated by c-Src Tyrosine Phosphorylation of IκBα* , 1998, The Journal of Biological Chemistry.

[32]  N. Perkins,et al.  Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB , 2004 .

[33]  Dimitris Thanos,et al.  Nucleosome Sliding via TBP DNA Binding In Vivo , 2001, Cell.

[34]  V. Pande,et al.  NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. , 2005, Current medicinal chemistry.

[35]  H. Pahl,et al.  Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.

[36]  S. Manna,et al.  Pervanadate-induced Nuclear Factor-κB Activation Requires Tyrosine Phosphorylation and Degradation of IκBα , 2000, The Journal of Biological Chemistry.

[37]  A. Hoffmann,et al.  CK2 Is a C-Terminal IkappaB Kinase Responsible for NF-kappaB Activation during the UV Response. , 2003, Molecular cell.

[38]  M. Gadjeva,et al.  A Role for NF-κB Subunits p50 and p65 in the Inhibition of Lipopolysaccharide-Induced Shock1 , 2004, The Journal of Immunology.

[39]  Ryuji Kobayashi,et al.  IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a , 2004, Cell.

[40]  A. Thiel,et al.  The IκB Kinase Complex and NF-κB Actas Master Regulators of Lipopolysaccharide-Induced Gene Expressionand Control Subordinate Activation ofAP-1 , 2004, Molecular and Cellular Biology.

[41]  R. Jain,et al.  The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis , 2004, Nature.

[42]  Michael Karin,et al.  IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.

[43]  Jennifer Y. Zhang,et al.  NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia , 2003, Nature.

[44]  James R. Johnson,et al.  Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression , 2004, Science.

[45]  J. Piette,et al.  Crucial Role of the Amino-Terminal Tyrosine Residue 42 and the Carboxyl-Terminal PEST Domain of IκBα in NF-κB Activation by an Oxidative Stress1 , 2000, The Journal of Immunology.

[46]  N. Perkins,et al.  NF-κB: tumor promoter or suppressor? , 2004 .

[47]  S. Saccani,et al.  p38-dependent marking of inflammatory genes for increased NF-κB recruitment , 2002, Nature Immunology.

[48]  David Baltimore,et al.  One Nucleotide in a κB Site Can Determine Cofactor Specificity for NF-κB Dimers , 2004, Cell.

[49]  M. Karin,et al.  IKKα controls formation of the epidermis independently of NF-κB , 2001, Nature.

[50]  A. Hoffmann,et al.  Immortalized fibroblasts from NF-κB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor α after transformation by v-Ras , 2005, Oncogene.

[51]  Jennifer Y. Zhang,et al.  NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK. , 2004, Genes & development.

[52]  C. Bracken,et al.  Activity of hypoxia-inducible factor 2alpha is regulated by association with the NF-kappaB essential modulator. , 2005, Journal of Biological Chemistry.

[53]  Michael Karin,et al.  Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases , 2005, Cell.

[54]  Toby Lawrence,et al.  IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. , 2005, Nature.

[55]  G. Courtois,et al.  TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2 , 2002, Nature.

[56]  S. Manna,et al.  Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha. , 2000, The Journal of biological chemistry.

[57]  G. Haegeman,et al.  The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. , 2003, Endocrine reviews.

[58]  Marty W. Mayo,et al.  Akt Stimulates the Transactivation Potential of the RelA/p65 Subunit of NF-κB through Utilization of the IκB Kinase and Activation of the Mitogen-activated Protein Kinase p38* , 2001, The Journal of Biological Chemistry.

[59]  Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. , 2005, The Journal of clinical investigation.

[60]  G. Wahl,et al.  p53 stabilization is decreased upon NFκB activation , 2002 .

[61]  N. Perkins,et al.  Post-translational modification of RelA ( p 65 ) NF-κ , 2004 .

[62]  Harikrishna Nakshatri,et al.  Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer , 2004, Investigational New Drugs.

[63]  C. Mueller-Dieckmann,et al.  Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α , 1996, Cell.

[64]  Hee June Choi,et al.  Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes , 2005, Nature.

[65]  H. Kwon,et al.  Hostile takeovers: viral appropriation of the NF-kB pathway , 2001 .

[66]  David F. Kashatus,et al.  NF-kappa B and I kappa B alpha are found in the mitochondria. Evidence for regulation of mitochondrial gene expression by NF-kappa B. , 2003, Journal of Biological Chemistry.

[67]  Bharat B. Aggarwal,et al.  Nuclear factor-κB: its role in health and disease , 2004, Journal of Molecular Medicine.

[68]  J. Cusack,et al.  Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB , 1999, Nature Medicine.

[69]  S. Saccani,et al.  Degradation of Promoter-bound p65/RelA Is Essential for the Prompt Termination of the Nuclear Factor κB Response , 2004, The Journal of experimental medicine.

[70]  N. Perkins,et al.  Regulation of NF-kappaB function. , 2006, Biochemical Society symposium.

[71]  N. Perkins,et al.  Post-translational modification of RelA(p65) NF-κB , 2004 .

[72]  A. Baldwin,et al.  NF-κB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism , 2003 .

[73]  S. Westerheide,et al.  PTEN Blocks Tumor Necrosis Factor-induced NF-κB-dependent Transcription by Inhibiting the Transactivation Potential of the p65 Subunit* , 2002, The Journal of Biological Chemistry.

[74]  Leonard Buckbinder,et al.  NF-kappaB RelA phosphorylation regulates RelA acetylation. , 2005, Molecular and cellular biology.

[75]  Michael Karin,et al.  IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis , 2005, Cell.

[76]  R. Gaynor,et al.  Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation. , 2005, Molecular cell.

[77]  S. Gringhuis,et al.  Convergent Actions of IκB Kinase β and Protein Kinase Cδ Modulate mRNA Stability through Phosphorylation of 14-3-3β Complexed with Tristetraprolin , 2005, Molecular and Cellular Biology.

[78]  G. Mann,et al.  Impaired inhibition of NF-kappaB activity by melanoma-associated p16INK4a mutations. , 2005, Biochemical and biophysical research communications.

[79]  G. Haegeman,et al.  p38 and Extracellular Signal-regulated Kinase Mitogen-activated Protein Kinase Pathways Are Required for Nuclear Factor-κB p65 Transactivation Mediated by Tumor Necrosis Factor* , 1998, The Journal of Biological Chemistry.

[80]  Jennifer Y. Zhang,et al.  CDK4 regulation by TNFR1 and JNK is required for NF-κB–mediated epidermal growth control , 2005, The Journal of cell biology.

[81]  A. Livolsi,et al.  Tumor necrosis factor-alpha activation of nuclear transcription factor-kappaB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of Ikappa Balpha. , 1998, The Journal of biological chemistry.

[82]  S. Saccani,et al.  Modulation of NF-kappaB activity by exchange of dimers. , 2003, Molecular cell.

[83]  J. Brady,et al.  Activated AKT regulates NF-κB activation, p53 inhibition and cell survival in HTLV-1-transformed cells , 2005, Oncogene.

[84]  A. Thiel,et al.  The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. , 2004, Molecular and cellular biology.

[85]  K. Yeh,et al.  Suppression of MEK/ERK Signaling Pathway Enhances Cisplatin-induced NF-κB Activation by Protein Phosphatase 4-mediated NF-κB p65 Thr Dephosphorylation* , 2004, Journal of Biological Chemistry.

[86]  Sankar Ghosh,et al.  Signaling to NF-kappaB. , 2004, Genes & development.

[87]  E. Kieff,et al.  IκB kinase β phosphorylates Dok1 serines in response to TNF, IL-1, or γ radiation , 2004 .

[88]  K. Vousden,et al.  Role of NF-κB in p53-mediated programmed cell death , 2000, Nature.

[89]  Michael Karin,et al.  The IKK NF-κB system: a treasure trove for drug development , 2004, Nature Reviews Drug Discovery.

[90]  T. Lawrence,et al.  Possible new role for NF-kappaB in the resolution of inflammation. , 2001, Nature medicine.

[91]  C. Gélinas,et al.  To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis , 2003, Oncogene.

[92]  C. Pham,et al.  NF-κB and JNK: An Intricate Affair , 2004 .

[93]  T. Gilmore,et al.  Mutations within a conserved protein kinase A recognition sequence confer temperature-sensitive and partially defective activities onto mouse c-Rel. , 2003, Biochemical and biophysical research communications.

[94]  N. Perkins.  Achieving transcriptional specificity with NF-kappa B. , 1997, The international journal of biochemistry & cell biology.

[95]  A. Hoffmann,et al.  One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. , 2004, Cell.

[96]  M. Hung,et al.  Crossregulation of NF‐κB by the APC/GSK‐3β/β‐catenin pathway , 2004, Molecular carcinogenesis.

[97]  A. Ryo,et al.  Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. , 2003, Molecular cell.

[98]  I. Verma,et al.  IκB Kinase-Independent IκBα Degradation Pathway: Functional NF-κB Activity and Implications for Cancer Therapy , 2003, Molecular and Cellular Biology.

[99]  T. Gilmore,et al.  Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-κB have a malignantly transformed phenotype , 2002, Oncogene.

[100]  J. Fujita,et al.  A novel protein overexpressed in hepatoma accelerates export of NF-kappa B from the nucleus and inhibits p53-dependent apoptosis. , 2002, Cancer cell.

[101]  M. Karin,et al.  The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .

[102]  Michael Karin,et al.  IKK/NF-κB signaling: balancing life and death – a new approach to cancer therapy , 2005 .

[103]  D. Seldin,et al.  Protein Kinase CK2 Promotes Aberrant Activation of Nuclear Factor-κB, Transformed Phenotype, and Survival of Breast Cancer Cells , 2002 .

[104]  S. Gargiulo,et al.  Inverse correlation between p16INK4A expression and NF-kappaB activation in melanoma progression. , 2004, Human pathology.

[105]  B. Aronow,et al.  Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. , 2004, The EMBO journal.

[106]  E. Pace,et al.  Inhibition of transcription factor NF-kappaB signaling proteins IKKbeta and p65 through specific cysteine residues by epoxyquinone A monomer: correlation with its anti-cancer cell growth activity. , 2006, Biochemical pharmacology.

[107]  J. Prehn,et al.  Activation of Nuclear Factor κb and bcl-x Survival Gene Expression by Nerve Growth Factor Requires Tyrosine Phosphorylation of IκBα , 2001, The Journal of cell biology.